Vergent Bioscience, Inc.

New Filing
CIK: 0001741495·Biotechnology·DELAWARE·Filed: Oct 4, 2022
Total Offering

$22,090,063

Amount Sold

$21,542,628

Investors

27

First Sale

Aug 17, 2022

Offering Details

Type
Equity
Exemptions
Rule 506(b)
Entity Type
Corporation
Non-Accredited Investors
No

Related Persons

NameRole
John Santini
Related Person
Jeffrey Julkowski
Related Person
Samuel Banks
Related Person
Douglas Kohrs
Related Person
Raymond Wong
Related Person
Jeffrey Yurecko
Related Person
Ryan Egeland
Related Person
Margo Shoup
Related Person

Company

Vergent Bioscience, Inc.

5810 W 78TH ST

MINNEAPOLIS, MN, 55439

9524263772

SEC Filing

0001741495-22-000001

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.

Sign Up Free
Vergent Bioscience, Inc. Form D Filing — $22,090,063 | FilingFlow